Endothelial cell dysfunction after coronary artery bypass grafting with extracorporeal circulation in patients with

Karla Lehle1, Jürgen G Preuner, Anja Vogt

  • 1Department of Cardiothoracic Surgery, University Hospital Regensburg, Franz-Josef-Strauss-Allee 11, D-93053 Regensburg, Germany. Karla.Lehle@klinik.uni-regensburg.de

Insights

Type 2 diabetes mellitus patients undergoing coronary artery bypass grafting (CABG) show specific endothelial dysfunction. Diabetic patients exhibit impaired interleukin-6 (IL-6) release and increased E-selectin turnover post-CABG.

Area of Science:

  • Cardiovascular Surgery
  • Endocrinology
  • Immunology

Background:

  • Type 2 diabetes mellitus is a significant risk factor for severe coronary artery disease.
  • Coronary artery bypass grafting (CABG) is a common surgical intervention for severe coronary artery disease.
  • Endothelial dysfunction is a key pathological process in cardiovascular disease.

Purpose of the Study:

  • To investigate endothelial dysfunction in patients with type 2 diabetes mellitus undergoing CABG.
  • To evaluate the release of soluble inflammatory cytokines, specifically E-selectin, interleukin-6 (IL-6), and tumor necrosis factor (TNF), postoperatively.
  • To analyze the kinetic profiles of these cytokines in diabetic versus non-diabetic patients.

Main Methods:

  • A comparative study of patients undergoing CABG, divided into two groups: without diabetes (n=15) and with type 2 diabetes mellitus (n=14).
  • Postoperative measurement of E-selectin, IL-6, and TNF levels up to 3 days.
  • Pharmacokinetic analysis using a non-compartmental model to determine maximum concentrations (c(max)), time to reach c(max) (t(max)), area under the curve (AUC(0-inf)), and terminal elimination half-time (t(1/2)).

Main Results:

  • No significant differences in preoperative cytokine levels or postoperative TNF kinetics between groups.
  • Diabetic patients (group B) showed significantly restricted IL-6 release (lower c(max) and AUC(0-inf)) compared to non-diabetic patients (group A).
  • E-selectin showed a significantly decreased AUC(0-inf) and reduced t(1/2) in diabetic patients, suggesting increased endothelial uptake and degradation.

Conclusions:

  • Coronary artery bypass grafting with extracorporeal circulation can reveal specific endothelial dysfunction in diabetic patients.
  • This dysfunction is characterized by impaired IL-6 release and augmented E-selectin turnover.
  • Findings highlight the distinct inflammatory and endothelial responses in diabetic patients undergoing CABG.
Abstract

Related Concept Videos

Type I Diabetes II: Pathophysiology01:26

Type I Diabetes II: Pathophysiology

Type 1 diabetes mellitus arises from an immune-mediated destruction of pancreatic β-cells, resulting in an absolute deficiency of insulin. This process develops in genetically susceptible individuals when autoimmunity, environmental exposures, and immunologic dysregulation converge to trigger a targeted attack on the insulin-producing cells of the pancreas. The β-cells are located within the islets of Langerhans and are essential for regulating blood glucose by facilitating cellular uptake of...
Type II Diabetes II: Pathophysiology01:24

Type II Diabetes II: Pathophysiology

PathophysiologyType 2 diabetes mellitus (T2DM ) is a chronic metabolic disorder characterized by insulin resistance and progressive pancreatic β-cell dysfunction, leading to impaired glucose homeostasis. It results from interactions among genetic predisposition, environmental factors, and metabolic stressors, such as overnutrition and a sedentary lifestyle.Insulin Resistance and Glucose DysregulationEarly T2DM involves insulin resistance in skeletal muscle, adipose tissue, and the liver.
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Diabetic Retinopathy01:27

Diabetic Retinopathy

DefinitionDiabetic retinopathy is a microvascular complication of diabetes affecting the retinal blood vessels.Risk FactorsDiabetic retinopathy is present in almost all individuals with type 1 diabetes and more than 60% of those with type 2 diabetes after two decades of disease.The risk increases with poor glycemic control, hypertension, dyslipidemia, smoking, pregnancy, and puberty.Although cataracts and glaucoma are also more frequent in people with diabetes, retinopathy remains the leading...
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility, suggesting a...
Peripheral Artery Disease V: Postoperative Nursing Management01:23

Peripheral Artery Disease V: Postoperative Nursing Management

During the postoperative period, it is crucial to focus on maintaining circulation, identifying and managing potential complications, and planning for discharge.Nursing AssessmentVital signs monitoring: Regularly monitor vital signs, including blood pressure, heart rate, respiratory rate, and temperature, to detect early signs of complications such as bleeding and infection.Circulation assessment: Monitor pulses, perform Doppler assessments, and check capillary refill, color, temperature, and...